• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,151.45 964.58
( 1.25%)
Global Indices
Nasdaq
52,169.86 -404.11
(-0.77%)
Dow Jones
7,480.34 -74.43
(-0.99%)
Hang Seng
63,887.74 -2,947.80
(-4.41%)
Nikkei 225
10,574.52 2.28
(0.02%)
Forex
USD-INR
96.36 0.10
(0.10%)
EUR-INR
110.37 0.25
(0.23%)
GBP-INR
130.11 0.62
(0.47%)
JPY-INR
0.59 0.00
(0.06%)

EQUITY - MARKET SCREENER

Dev Information Technology Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
543462
INE060X01034
19.5715884
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DEVIT
229.17
155
EPS(TTM)
Face Value()
Div & Yield %
0.12
2
0.36
 

kotak mahindra bank ltd
Dr Reddy’s Labs receives seven USFDA observations for Hyderabad facility
Jun 26,2026
At the conclusion of the inspection, USFDA issued a Form-483 with seven observations. The company said it will address within the stipulated timeline.

Previously, the USFDA had conducted a Pre-Approval Inspection (PAI) at the same Hyderabad facility between 4 September and 12 September 2025, following which it had issued five observations.

Hyderabad-based Dr. Reddy’s Laboratories is a global pharmaceutical company. It offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC.

The company reported a 86.14% decline in consolidated net profit to Rs 220.9 crore on 11.51% drop in revenue from operations to Rs 7,546.4 crore in Q4 FY26 over Q4 FY25.

The counter advanced 1.63% to settle at Rs 1,350 on Thursday, 25th June 2026. The NSE and BSE remain closed today on account of Muharram.